Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Selling 50% of shares @$1.35 (one dollar, thirty five cents
View:
Post by PowerofNow on Mar 18, 2021 3:10pm

Selling 50% of shares @$1.35 (one dollar, thirty five cents

With so much noise on the board folks, you have to remember the psychology behind holding a stock and sticking to the ultimate goal. My sell order is at $1.35. No less.
Comment by TradeMagician on Mar 18, 2021 4:02pm
PowerofNow: $1.36 is way too cheap for a compamy with so much raw potential.  My goal is to sell half my shares at 10X your target. That's right, I'm not selling even a single share for less than $13.50/share.  If you aren't thinking big then you are aleady a loser in this investing game.   Think big if you want to be big.
Comment by Bigginvestor on Mar 18, 2021 5:57pm
lol wow $ 13 .shiiit that is big ok
Comment by PowerofNow on Mar 19, 2021 4:46pm
Whooa, ok thats a huge target $13.50 / share... I see it plausibility because of other hype stocks that took off even before product release. SONA for instance ran to $16 before production.
Comment by 011Peking on Mar 19, 2021 8:04am
Same but my thought is to..with my 600k shares sell 100k around 1-2$ and let the rest 500k work as long as it wants. 10$+ in a couple of years would have been like a dream!
Comment by PTBailey on Mar 19, 2021 11:12am
I wish and dream of $10, would love to see it obviously but would settle for less to take out my initial investment. I have 1.3mil so at .25 will sell enough to get out my costs. My average is about .04
Comment by Malfuncion on Mar 19, 2021 11:43am
Wtf what’s this another pump
Comment by Bigginvestor on Mar 19, 2021 12:11pm
those numbers are good . But I'll take it it at .25 or .40 cent's DNT want to be to greedy.
Comment by Kobedog1 on Mar 19, 2021 12:45pm
When you get to decision time, only then will you know who you really are... not before. Best wishes.
Comment by wetbehindears on Mar 19, 2021 1:15pm
I am curious when you think this stock with low volume and a scary balance sheet is getting to $1.35? I am NOT being negative, just would like to see some sound reasoning of how we get to that number and perhaps when?
Comment by PowerofNow on Mar 19, 2021 3:46pm
Low Volume? Are you kidding me this stock has one of the highest volumes in its entire exchange! Simple, the fact is this product works against killing the spike protein in New age virus. Stick to the facts, the company has been granted mad money from different parts of globe. Its all in the money and facts.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities